Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

Podcasts

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals More

Online First

April 09, 2020

Systemic lupus erythematosus
Laboratory investigation results influence Physician’s Global Assessment (PGA) of disease activity in SLE

Cynthia Aranow, Anca Askanase, Shereen Oon, Molla Huq, Alicia Calderone, Eric F Morand, Mandana Nikpour

doi: 10.1136/annrheumdis-2019-216753

April 08, 2020

Osteoarthritis
Horizontal fissuring at the osteochondral interface: a novel and unique pathological feature in patients with obesity-related osteoarthritis

Lianzhi Chen, Felix Yao, Tao Wang, Guangyi Li, Peilin Chen, Max Bulsara, Jessica Jun Yi Zheng, Euphemie Landao-Bassonga, Marty Firth, Praveen Vasantharao, Yigang Huang, Michelle Lorimer, Stephen Graves, Junjie Gao, Richard Carey-Smith, John Papadimitriou, Changqing Zhang, David Wood, Christopher Jones, Minghao Zheng

doi: 10.1136/annrheumdis-2020-216942

April 07, 2020

Rheumatoid arthritis
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis

Andreas Kerschbaumer, Alexandre Sepriano, Josef S Smolen, Désirée van der Heijde, Maxime Dougados, Ronald van Vollenhoven, Iain B McInnes, Johannes W J Bijlsma, Gerd R Burmester, Maarten de Wit, Louise Falzon, Robert Landewé

doi: 10.1136/annrheumdis-2019-216656
Correspondence response
Response to: ‘Reactive arthritis, a missing link: comment on the recent article from Sepriano et al’ by Zeidler and Hudson
Free

Alexandre Sepriano, Sofia Ramiro, Désirée van der Heijde, Robert B M Landewé

doi: 10.1136/annrheumdis-2020-217347

April 06, 2020

Epidemiology
Associations of regular glucosamine use with all-cause and cause-specific mortality: a large prospective cohort study

Zhi-Hao Li, Xiang Gao, Vincent CH Chung, Wen-Fang Zhong, Qi Fu, Yue-Bin Lv, Zheng-He Wang, Dong Shen, Xi-Ru Zhang, Pei-Dong Zhang, Fu-Rong Li, Qing-Mei Huang, Qing Chen, Wei-Qi Song, Xian-Bo Wu, Xiao-Ming Shi, Virginia Byers Kraus, Xingfen Yang, Chen Mao

doi: 10.1136/annrheumdis-2020-217176
Spondyloarthritis
Dual neutralisation of interleukin-17A and interleukin-17F with bimekizumab in patients with active ankylosing spondylitis: results from a 48-week phase IIb, randomised, double-blind, placebo-controlled, dose-ranging study

Désirée van der Heijde, Lianne S Gensler, Atul Deodhar, Xenofon Baraliakos, Denis Poddubnyy, Alan Kivitz, Mary Katherine Farmer, Dominique Baeten, Nadine Goldammer, Jason Coarse, Marga Oortgiesen, Maxime Dougados

doi: 10.1136/annrheumdis-2020-216980

April 03, 2020

Correspondence
Successful treatment of plasma exchange for refractory systemic juvenile idiopathic arthritis complicated with macrophage activation syndrome and severe lung disease
Free

Satoshi Sato, Takahiro Hosokawa, Hisashi Kawashima

doi: 10.1136/annrheumdis-2020-217390
Rheumatoid arthritis
Economic burden of rheumatoid arthritis: a systematic review of literature in biologic era

Ping-Hsuan Hsieh, Olivia Wu, Claudia Geue, Emma McIntosh, Iain B McInnes, Stefan Siebert

doi: 10.1136/annrheumdis-2019-216243
Letter
Immunoscintigraphy in axial spondyloarthritis: a new imaging modality for sacroiliac inflammation

Philippe Carron, Thomas Renson, Manouk de Hooge, Bieke Lambert, Kathia De Man, Lennart Jans, Dirk Elewaut, Filip E Van den Bosch

doi: 10.1136/annrheumdis-2020-216993

April 02, 2020

Letter
To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic
Free

Francesca Romana Spinelli, Fulvia Ceccarelli, Manuela Di Franco, Fabrizio Conti

doi: 10.1136/annrheumdis-2020-217367
Letter
Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies

Sara Monti, Silvia Balduzzi, Paolo Delvino, Elisa Bellis, Verdiana Serena Quadrelli, Carlomaurizio Montecucco

doi: 10.1136/annrheumdis-2020-217424
Letter
COVID-19 in a patient with systemic sclerosis treated with tocilizumab for SSc-ILD
Free

Carina Mihai, Rucsandra Dobrota, Maria Schröder, Alexandru Garaiman, Suzana Jordan, Mike Oliver Becker, Britta Maurer, Oliver Distler

doi: 10.1136/annrheumdis-2020-217442
Systemic lupus erythematosus
Risk of systemic lupus erythematosus in patients with idiopathic thrombocytopenic purpura: a population-based cohort study

Fang-Xiao Zhu, Jing-Yang Huang, Zhizhong Ye, Qing-Qing Wen, James Cheng-Chung Wei

doi: 10.1136/annrheumdis-2020-217013
Correspondence
Imaging in immune checkpoint inhibitor-induced polymyalgia rheumatica

Kornelis S M van der Geest, Maria Sandovici, Abraham Rutgers, T Jeroen N Hiltermann, Sjoukje F Oosting, Riemer H J A Slart, Elisabeth Brouwer

doi: 10.1136/annrheumdis-2020-217381
Rheumatoid arthritis
Two-year cost-effectiveness of different COBRA-like intensive remission induction schemes in early rheumatoid arthritis: a piggyback study on the pragmatic randomised controlled CareRA trial

Sofia Pazmino, Annelies Boonen, Veerle Stouten, Diederik De Cock, Johan Joly, Kristien Van der Elst, Rene Westhovens, Patrick Verschueren

doi: 10.1136/annrheumdis-2019-216874
Correspondence response
Response to: ‘Glucocorticoid withdrawal in lupus: to do or not to do?’ by Acharya
Free

Alexis Mathian, Micheline Pha, Zahir Amoura

doi: 10.1136/annrheumdis-2020-217282
Correspondence
Autoantibodies and interstitial lung disease in rheumatoid arthritis: towards a ‘mix-and-match’ approach?
Free

Alessia Alunno, Onelia Bistoni, Angelo Francesco Bonifacio, Roberto Gerli

doi: 10.1136/annrheumdis-2020-217410

April 01, 2020

Crystal arthropathies
Subtype-specific gout susceptibility loci and enrichment of selection pressure on ABCG2 and ALDH2 identified by subtype genome-wide meta-analyses of clinically defined gout patients

Akiyoshi Nakayama, Masahiro Nakatochi, Yusuke Kawamura, Ken Yamamoto, Hirofumi Nakaoka, Seiko Shimizu, Toshihide Higashino, Teruhide Koyama, Asahi Hishida, Kiyonori Kuriki, Miki Watanabe, Toru Shimizu, Keiko Ooyama, Hiroshi Ooyama, Mitsuo Nagase, Yuji Hidaka, Daisuke Matsui, Takashi Tamura, Takeshi Nishiyama, Chisato Shimanoe, Sakurako Katsuura-Kamano, Naoyuki Takashima, Yuya Shirai, Makoto Kawaguchi, Mikiya Takao, Ryo Sugiyama, Yuzo Takada, Takahiro Nakamura, Hiroshi Nakashima, Masashi Tsunoda, Inaho Danjoh, Atsushi Hozawa, Kazuyoshi Hosomichi, Yu Toyoda, Yu Kubota, Tappei Takada, Hiroshi Suzuki, Blanka Stiburkova, Tanya J. Major, Tony R. Merriman, Nagato Kuriyama, Haruo Mikami, Toshiro Takezaki, Keitaro Matsuo, Sadao Suzuki, Tatsuo Hosoya, Yoichiro Kamatani, Michiaki Kubo, Kimiyoshi Ichida, Kenji Wakai, Ituro Inoue, Yukinori Okada, Nariyoshi Shinomiya, Hirotaka Matsuo on behalf of Japan Gout Genomics Consortium (Japan Gout)

doi: 10.1136/annrheumdis-2019-216644

March 31, 2020

Osteoarthritis
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period

Francis Berenbaum, Francisco J Blanco, Ali Guermazi, Kenji Miki, Takaharu Yamabe, Lars Viktrup, Rod Junor, William Carey, Mark T Brown, Christine R West, Kenneth M Verburg

doi: 10.1136/annrheumdis-2019-216296

March 30, 2020

Correspondence
Terminology and definition of ‘antinuclear antibodies’: history and current debate
Free

Robert Daniel Heinrich Markewitz, Klaus-Peter Wandinger

doi: 10.1136/annrheumdis-2020-217166
Correspondence
MRI and ultrasonography are useful tools for a non-invasive diagnosis of IgG4-related disease
Free

Augustin Lecler, Thomas Sené

doi: 10.1136/annrheumdis-2020-217352

March 27, 2020

Recommendation
2019 Update of the Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the management of lupus nephritis
Free

Antonis Fanouriakis, Myrto Kostopoulou, Kim Cheema, Hans-Joachim Anders, Martin Aringer, Ingeborg Bajema, John Boletis, Eleni Frangou, Frederic A Houssiau, Jane Hollis, Adexandre Karras, Francesca Marchiori, Stephen D Marks, Gabriella Moroni, Marta Mosca, Ioannis Parodis, Manuel Praga, Matthias Schneider, Josef S Smolen, Vladimir Tesar, Maria Trachana, Ronald F van Vollenhoven, Alexandre E Voskuyl, Y K Onno Teng, Bernadette van Leew, George Bertsias, David Jayne, Dimitrios T Boumpas

doi: 10.1136/annrheumdis-2020-216924

March 25, 2020

Letter
Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study

Augustin Latourte, Hang-Korng Ea, Aline Frazier, Anne Blanchard, Frédéric Lioté, Hubert Marotte, Thomas Bardin, Pascal Richette

doi: 10.1136/annrheumdis-2020-217188
Correspondence
Prevalence of comorbidities and risk factors in spondyloarthritis: results of a cross-sectional study
Free

Yupeng Lai, Yanpeng Zhang, Shaozhen Mo, Jinsheng Ma, Tongxin Ni, Zhihao Lei, Jun Xia, Chiduo Xu

doi: 10.1136/annrheumdis-2020-217313
Letter
Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis

Saki Kuwabara, Shun Tanimura, Shogo Matsumoto, Hiroyuki Nakamura, Tetsuya Horita

doi: 10.1136/annrheumdis-2019-216606
Vasculitis
Targeting JAK/STAT pathway in Takayasu’s arteritis

Paul Régnier, Alexandre Le Joncour, Anna Maciejewski-Duval, Anne-Claire Desbois, Cloé Comarmond, Michelle Rosenzwajg, David Klatzmann, Patrice Cacoub, David Saadoun

doi: 10.1136/annrheumdis-2019-216900
Imaging
Ultrasound Doppler and tenosynovial fluid analysis in tenosynovitis

Fawad Aslam, Bryant R England, Amy Cannella, Veronika Sharp, Lily Kao, Jon Arnason, Jemima Albayda, Catherine Bakewell, Shruti Sanghvi, Robert Fairchild, Karina D Torralba, Amy Evangelisto, Paul J DeMarco, Narandra Bethina, Eugene Y Kissin

doi: 10.1136/annrheumdis-2020-216927
Correspondence response
Response to: ‘Immune-mediated necrotizing myopathies and interstitial lung disease are predominant characteristics in anti-Ku positive patients with idiopathic inflammatory myopathies’ by Yang et al
Free

Lionel Spielmann, Benoit Nespola, Alain Meyer

doi: 10.1136/annrheumdis-2020-217106
Correspondence
Reactive arthritis, a missing link: comment on the recent article from Sepriano et al
Free

Henning Zeidler, Alan P Hudson

doi: 10.1136/annrheumdis-2020-217326
Correspondence response
Response to: ‘Can sexual dimorphism in rheumatoid arthritis be attributed to the different abundance of Gardnerella?’ by Liu et al
Free

Toshihiro Kishikawa, Yuichi Maeda, Takuro Nii, Yukinori Okada

doi: 10.1136/annrheumdis-2020-217264
Letter
Patient discussions of glucocorticoid-related side effects within an online health community forum

Arani Vivekanantham, Maksim Belousov, Lamiece Hassan, Goran Nenadic, William G Dixon

doi: 10.1136/annrheumdis-2019-216791
Letter
Significant weight loss in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

Michael Hughes, Calvin Heal, Elise Siegert, Eric Hachulla, Paolo Airó, Antonella Riccardi, Oliver Distler, Marco Matucci-Cerinic On behalf of the EUSTAR Collaborators

doi: 10.1136/annrheumdis-2020-217035

March 24, 2020

Rheumatoid arthritis
Immunosuppression and the risk of readmission and mortality in patients with rheumatoid arthritis undergoing hip fracture, abdominopelvic and cardiac surgery

Michael D George, Joshua F Baker, Kevin L Winthrop, Seth D Goldstein, E Alemao, Lang Chen, Qufei Wu, Fenglong Xie, Jeffrey R Curtis

doi: 10.1136/annrheumdis-2019-216802
Thinking the unthinkable
Rare diseases 2030: how augmented AI will support diagnosis and treatment of rare diseases in the future

Martin Christian Hirsch, Simon Ronicke, Martin Krusche, Annette Doris Wagner

doi: 10.1136/annrheumdis-2020-217125

March 23, 2020

Osteoarthritis
Faecal microbiota transplantation from metabolically compromised human donors accelerates osteoarthritis in mice

ZeYu Huang, Jing Chen, BoLei Li, Benhua Zeng, Ching-Heng Chou, Xin Zheng, JingWei Xie, Hao Li, Yu Hao, Guo Chen, FuXing Pei, Bin Shen, Virginia B Kraus, Hong Wei, Xuedong Zhou, Lei Cheng

doi: 10.1136/annrheumdis-2019-216471

March 22, 2020

Letter
Are my patients with rheumatic diseases at higher risk of COVID-19?
Free

Gabriel Figueroa-Parra, Gloria Mayela Aguirre-Garcia, Carmen Magdalena Gamboa-Alonso, Adrian Camacho-Ortiz, Dionicio Angel Galarza-Delgado

doi: 10.1136/annrheumdis-2020-217322

March 18, 2020

Correspondence
Can sexual dimorphism in rheumatoid arthritis be attributed to the different abundance of Gardnerella?
Free

Dongsong Liu, Feng Zhang, Hong Cao, Xuesong Wang

doi: 10.1136/annrheumdis-2020-217214
Viewpoint
Disruptive innovation in rheumatology: new networks of global public–private partnerships are needed to take advantage of scientific progress

Tom WJ Huizinga, V Michael Holers, Jennifer Anolik, Michael B Brenner, Christopher Dominic Buckley, Vivian Bykerk, Sean E Connolly, Kevin D Deane, Jianping Guo, Martin Hodge, Steve Hoffmann, Frank Nestle, Costantino Pitzalis, Soumya Raychaudhuri, Kazuhiko Yamamoto, Zhanguo Li, Lars Klareskog

doi: 10.1136/annrheumdis-2019-216846
Correspondence
Features of polymyalgia rheumatica–like syndrome after immune checkpoint inhibitor therapy
Free

Gregoire Martin de Fremont, Rakiba Belkhir, Julien Henry, Anne Laure Voisin, Olivier Lambotte, Florent L Besson, Xavier Mariette, Gaetane Nocturne

doi: 10.1136/annrheumdis-2020-217225
Correspondence
Comments on the article: “Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial”
Free

Mohammad Reza Mousavi, Erfan Taherifard

doi: 10.1136/annrheumdis-2020-217287

March 16, 2020

Inflammatory arthritis
Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic Escherichia coli (DEC)

Riitta Tuompo, Tinja Lääveri, Timo Hannu, Sari H Pakkanen, Juha Kirveskari, Marjatta Leirisalo-Repo, Anu Kantele

doi: 10.1136/annrheumdis-2019-216736

March 13, 2020

Correspondence
Secukinumab efficacy in patients with PsA is not dependent on patients’ body mass index
Free

Ilenia Pantano, Daniela Iacono, Ennio Giulio Favalli, Giuseppe Scalise, Luisa Costa, Francesco Caso, Giuliana Guggino, Raffaele Scarpa, Francesco Ciccia

doi: 10.1136/annrheumdis-2020-217251

March 11, 2020

Letter
Long-term effectiveness of live herpes zoster vaccine in patients with rheumatoid arthritis subsequently treated with tofacitinib

Kevin L Winthrop, Ann Wouters, Ernest H Choy, Connie Chen, Pinaki Biswas, Lisy Wang, Koshika Soma, Elie Needle, Hernan Valdez, William FC Rigby

doi: 10.1136/annrheumdis-2019-216566
Inflammatory arthritis
Risk of neuroinflammatory events in arthritis patients treated with tumour necrosis factor alpha inhibitors: a collaborative population-based cohort study from Denmark and Sweden

Tine Iskov Kopp, Bénédicte Delcoigne, Elizabeth V Arkema, Rikke Kart Jacobsen, Melinda Magyari, Else Helene Ibfelt, Henning Locht, Finn Sellebjerg, Rene Lindholm Cordtz, Dorte V Jensen, Johan Askling, Lene Dreyer

doi: 10.1136/annrheumdis-2019-216693
Rheumatoid arthritis
Risk of breast cancer before and after rheumatoid arthritis, and the impact of hormonal factors

Hjalmar Wadström, Andreas Pettersson, Karin E Smedby, Johan Askling

doi: 10.1136/annrheumdis-2019-216756
Treatment
Initial combination therapy of ambrisentan and tadalafil in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH) in the modified intention-to-treat population of the AMBITION study: post hoc analysis

Masataka Kuwana, Christiana Blair, Tomohiko Takahashi, Jonathan Langley, John G Coghlan

doi: 10.1136/annrheumdis-2019-216274

March 10, 2020

Correspondence
Glucocorticoid withdrawal in lupus – to do or not to do?
Free

Nupoor Acharya

doi: 10.1136/annrheumdis-2020-217261
Correspondence response
A second case of dupilumab for the treatment of IgG4-related disease. Response to: ‘Comment on article: ‘Dupilumab as a novel steroid-sparing treatment for IgG4-related disease’ by Simpson et al’ by Ebbo et al
Free

Rachel S Simpson, Jason K Lee

doi: 10.1136/annrheumdis-2020-217029
Osteoarthritis
Metformin limits osteoarthritis development and progression through activation of AMPK signalling

Jun Li, Bin Zhang, Wei-Xiao Liu, Ke Lu, Haobo Pan, Tingyu Wang, Chun-do Oh, Dan Yi, Jian Huang, Lan Zhao, Guangzhi Ning, Cong Xing, Guozhi Xiao, Ru Liu-Bryan, Shiqing Feng, Di Chen

doi: 10.1136/annrheumdis-2019-216713
Rheumatoid arthritis
Anti-carbamylated proteins antibody repertoire in rheumatoid arthritis: evidence of a new autoantibody linked to interstitial lung disease

Raul Castellanos-Moreira, Sebastian Cruz Rodríguez-García, Maria Jose Gomara, Virginia Ruiz-Esquide, Andrea Cuervo, Ivette Casafont-Solé, Julio Ramírez, Susana Holgado, Jose A Gómez-Puerta, Juan D Cañete, Isabel Haro, Raimon Sanmarti

doi: 10.1136/annrheumdis-2019-216709

Log in using your username and password

Main menu

Log in using your username and password

You are here

Online First

April 09, 2020

April 08, 2020

April 07, 2020

April 06, 2020

April 03, 2020

April 02, 2020

April 01, 2020

March 31, 2020

March 30, 2020

March 27, 2020

March 25, 2020

March 24, 2020

March 23, 2020

March 22, 2020

March 18, 2020

March 16, 2020

March 13, 2020

March 11, 2020

March 10, 2020

Pages